SCHEMBL5633265

SCHEMBL5633265

CCCCN1C(=O)C(=C(N)N)C(=O)N(CC2CCCCC2)C1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.36
TRPA1 O75762 3/20 0.34
MMP1 P03956 1/20 0.34
MMP3 P08254 1/20 0.34
MMP9 P14780 1/20 0.34
ALDH1A1 P00352 1/20 0.34
MAPT P10636 1/20 0.34
PDE4A P27815 1/20 0.34
PDE4B Q07343 1/20 0.34
PDE4C Q08493 1/20 0.34
PDE4D Q08499 1/20 0.34
KMT2A Q03164 1/20 0.34
CYP1A2 P05177 1/20 0.33
CYP19A1 P11511 1/20 0.33
CTSK P43235 1/20 0.32
OPRM1 P35372 1/20 0.32
OPRL1 P41146 1/20 0.32
BACE1 P56817 1/20 0.32
BACE2 Q9Y5Z0 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30943067 0.87 TLR7 (0.35) AGTR1L3MBTL1ALDH1A1MAPT
SCHEMBL5633422 0.83 MAPT (0.43) L3MBTL1ALDH1A1MAPTKMT2ACYP1A2
SCHEMBL5633330 0.82 CDC25B (0.38) L3MBTL1ALDH1A1MAPTCYP19A1BACE1
SCHEMBL5633433 0.82 CDC25B (0.38) L3MBTL1ALDH1A1MAPTCYP19A1BACE1
SCHEMBL5634034 0.82 CDC25B (0.38) L3MBTL1ALDH1A1MAPTCYP19A1BACE1
SCHEMBL5634058 0.80 CDC25B (0.37) L3MBTL1ALDH1A1MAPTCYP19A1BACE1
SCHEMBL30942760 0.79 ADORA1 (0.32) AGTR1L3MBTL1KMT2A
SCHEMBL5634017 0.76 AGTR1 (0.36) AGTR1L3MBTL1TRPA1MMP1MMP3
SCHEMBL30943167 0.73 ALDH1A1 (0.33) L3MBTL1ALDH1A1MAPTCYP19A1
SCHEMBL31721493 0.73 KMT2A (0.32) L3MBTL1MMP1MMP3MMP9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070123548-A1 Pth agonists COWAN DAVID J 2007-05-31 US claimed
US-20070123548-A1 Pth agonists COWAN DAVID J 2007-05-31 US disclosed
EP-1713782-A1 PTH AGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2006-10-25 EP disclosed
WO-2005077918-A1 PTH AGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2005-08-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070123548-A1 Pth agonists PTH1R, SSTR3, CALCR AGTR1 168/4885L3MBTL1 4667/4885TRPA1 1387/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.